BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21992804)

  • 41. Preparation and biological evaluation of conformationally constrained BACE1 inhibitors.
    Winneroski LL; Schiffler MA; Erickson JA; May PC; Monk SA; Timm DE; Audia JE; Beck JP; Boggs LN; Borders AR; Boyer RD; Brier RA; Hudziak KJ; Klimkowski VJ; Garcia Losada P; Mathes BM; Stout SL; Watson BM; Mergott DJ
    Bioorg Med Chem; 2015 Jul; 23(13):3260-8. PubMed ID: 26001341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
    Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011).
    Probst G; Xu YZ
    Expert Opin Ther Pat; 2012 May; 22(5):511-40. PubMed ID: 22512789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors.
    Chirapu SR; Pachaiyappan B; Nural HF; Cheng X; Yuan H; Lankin DC; Abdul-Hay SO; Thatcher GR; Shen Y; Kozikowski AP; Petukhov PA
    Bioorg Med Chem Lett; 2009 Jan; 19(1):264-74. PubMed ID: 19013792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspartic proteases in drug discovery.
    Eder J; Hommel U; Cumin F; Martoglio B; Gerhartz B
    Curr Pharm Des; 2007; 13(3):271-85. PubMed ID: 17313361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.
    Klaver DW; Wilce MC; Cui H; Hung AC; Gasperini R; Foa L; Small DH
    Biol Chem; 2010 Aug; 391(8):849-59. PubMed ID: 20731541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of BACE-1 inhibitors utilizing a tertiary hydroxyl motif as the transition state mimic.
    Wångsell F; Russo F; Sävmarker J; Rosenquist A; Samuelsson B; Larhed M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4711-4. PubMed ID: 19576765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of pyrazole as C-terminus of selective BACE1 inhibitors.
    Zou Y; Xu L; Chen W; Zhu Y; Chen T; Fu Y; Li L; Ma L; Xiong B; Wang X; Li J; He J; Zhang H; Xu Y; Li J; Shen J
    Eur J Med Chem; 2013 Oct; 68():270-83. PubMed ID: 23988410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
    Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
    Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiinflammatory triterpenoids from the fruiting bodies of Fomitopsis pinicola.
    Kuo PC; Tai SH; Hung CC; Hwang TL; Kuo LM; Lam SH; Cheng KC; Kuo DH; Hung HY; Wu TS
    Bioorg Chem; 2021 Mar; 108():104562. PubMed ID: 33358389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
    Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of α-phenylnorstatine and α-benzylnorstatine as transition state isostere motifs in the search for new BACE-1 inhibitors.
    Wångsell F; Nordeman P; Sävmarker J; Emanuelsson R; Jansson K; Lindberg J; Rosenquist S; Samuelsson B; Larhed M
    Bioorg Med Chem; 2011 Jan; 19(1):145-55. PubMed ID: 21183353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study.
    Ahmad SS; Akhtar S; Danish Rizvi SM; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):311-318. PubMed ID: 28413992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.
    Wang X; Wang Y; Hu JP; Yu S; Li BK; Cui Y; Ren L; Zhang LD
    Mol Neurobiol; 2017 May; 54(4):2939-2949. PubMed ID: 27023226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
    Kakizawa T; Hidaka K; Hamada D; Yamaguchi R; Uemura T; Kitamura H; Tagad HD; Hamada T; Ziora Z; Hamada Y; Kimura T; Kiso Y
    J Pept Sci; 2010 Jun; 16(6):257-62. PubMed ID: 20474036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Green tea catechins as a BACE1 (beta-secretase) inhibitor.
    Jeon SY; Bae K; Seong YH; Song KS
    Bioorg Med Chem Lett; 2003 Nov; 13(22):3905-8. PubMed ID: 14592472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of BACE1 Activity by a DNA Aptamer in an Alzheimer's Disease Cell Model.
    Liang H; Shi Y; Kou Z; Peng Y; Chen W; Li X; Li S; Wang Y; Wang F; Zhang X
    PLoS One; 2015; 10(10):e0140733. PubMed ID: 26473367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KMI-358 and KMI-370, highly potent and small-sized BACE1 inhibitors containing phenylnorstatine.
    Kimura T; Shuto D; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Hattori C; Asai M; Kitazume S; Saido TC; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1527-31. PubMed ID: 15006396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of morpholine derivatives using the Castagnoli-Cushman reaction as BACE1 inhibitors: Unexpected binding activity of cyclic thioamides.
    Calugi L; Lenci E; Innocenti R; Trabocchi A
    Bioorg Med Chem Lett; 2020 Jul; 30(13):127211. PubMed ID: 32354570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.